Description
TACS•XL® DABKitisdesignedforusewithfixedfrozenorparaffinembeddedtissuesections. AllthereagentsrequiredforthelabelinganddetectionoffragmentedDNAandtoassistintheidentificationofapoptoticmorphologiesareprovidedincludingtwopermeABIlizationreagents,labelinganddetectionreagents,stopbuffers,DABandMethylGreen counterstain aswellas TACS-Nuclease™forgeneratingpositivecontrolswithyourownsamples.
Pleaserefertoourcomponentslistingfordetails.
| Catalog#4828-30-DKincludes: | ||
| CatalogNumber | Description | Qty |
| 4800-30-01 | ProteinaseK | 1 |
| 4800-30-06 | Streptavidin-HRP | 1 |
| 4800-30-07 | Diaminobenzidine | 1 |
| 4800-30-09 | DABEnhancer | 1 |
| 4800-30-15 | TACS-Nuclease™ | 1 |
| 4800-30-16 | TACS-Nuclease™Buffer | 1 |
| 4800-30-18 | MethylGreen1% | 1 |
| 4810-30-02 | TACS®2TdTLabelingBuffer | 1 |
| 4810-30-03 | TACS®2TdTStopBuffer | 1 |
| 4810-30-05 | TdTEnzyme | 1 |
| 4828-30-04 | B-dNTPMix | 1 |
| 4828-30-06 | anti-BrdUantibody | 1 |
| 4828-30-12 | Strep-Diluent | 1 |
| 4876-05-01 | Cytonin™ | 1 |
Anti-YKL-40antibodyandionizingirrADIationsynergisticallyinhibittumorvascularizationandmalignancyinglioblastoma
Shao,R.,Francescone,R.,Ngernyuang,N.,Bentley,B.,Taylor,S.L.,Moral,L.,andYan,W.,Anti-YKL-40antibodyandionizingirradiationsynergisticallyinhibittumorvascularizationandmalignancyinglioblastoma41671CarcinogenesisCarcinogenesis373
Carcinogenesis,Feb2014;35:373–382
http://carcin.oxfordjournals.org/cgi/content/abstract/35/2/373
HepaticSerumAmyloidA1AggravatesTCell-mediatedHepatitisbyInducingChemokinesviaToll-likeReceptor2inMice
“YoungRaeJi,HeiJungKim,KiBeomBae,SanggyuLee,MyoungOkKim,andZaeYoungRyoo”
J.Biol.Chem.,May2015;290:12804–12811.
http://www.jbc.org/cgi/content/abstract/290/20/12804
PersistenteffectofmTORinhibitiononpreneoplasticfociprogressionandgeneexpressioninaratmodelofhepatocellularcarcinoma
HeatherFrancois-Vaughan,AdeolaO.Adebayo,KateE.Brilliant,NicolaM.A.Parry,PhilipA.Gruppuso,andJenniferA.Sanders
Carcinogenesis,Apr2016;37:408–419.
http://carcin.oxfordjournals.org/cgi/content/abstract/37/4/408
“MechaNISTicTargetofRapamycin(mTOR)InhibitionSynergizeswith
ReducedInternalRibosomeEntrySite(IRES)-mediatedTranslationof
CyclinD1andc-MYCmRNAstoTreatGlioblastoma”
“BrentHolmes,JihyeLee,KennaA.Landon,AngelicaBenavides-Serrato,TariqBashir,MichaelE.Jung,AlanLichtenstein,andJosephGera”
J.Biol.Chem.,Jul2016;291:14146–14159.
http://www.jbc.org/cgi/content/abstract/291/27/14146
